Vaccine revenue

In the first nine months of this year, Pfizer’s (PFE) vaccines sales grew ~7% YoY (year-over-year) to $4.7 billion from $4.4 billion. US vaccine sales grew ~2% to $2.7 billion, while international vaccine sales grew ~15% YoY to $2.0 billion. Internationally, Pfizer’s vaccine operations grew ~13% YoY.

In the third quarter, Pfizer’s vaccine revenue grew ~12% YoY to $1.8 billion. US and international vaccines sales grew ~14% and 9% YoY, respectively, to $1.1 billion and $695.0 million.

Pfizer’s Vaccines: A Look at Their Market Performance

Trumenba and TicoVac revenue

Revenue from Trumenba, a meningococcal group B vaccine, grew ~20% YoY to $95.0 million in the first nine months of this year, and ~46% YoY to $61.0 million in the third quarter. Revenue from Pfizer’s TicoVac, a tick-borne encephalitis vaccine, grew ~36% YoY to $162.0 million in the first nine months of this year, and 31% YoY to $57.0 million from $43.0 million in the third quarter.

In the third quarter, revenue for vaccine peers GlaxoSmithKline (GSK), Merck (MRK), and Sanofi (SNY) grew ~2.78%, ~4.54%, and 2.66% YoY, respectively, to $10.5 billion, $10.8 billion, and $10.9 billion. Pfizer’s and Merck’s revenue growth could boost the First Trust NASDAQ Pharmaceutical ETF (FTXH), of which PFE and MRK comprise ~9.56% and ~5.10%, respectively.

Latest articles

Marathon Petroleum (MPC) stock has been tumbling in Q3, driven by geopolitical tensions, oil price uncertainty, and weaker refining conditions.

This week, AT&T CEO Randall Stephenson noted that AT&T (T) is on track to reduce its leverage multiple to about 2.5x by the end of this year.

Jeff Bezos announced that Amazon had placed an order of 100,000 electric delivery vans from Michigan-based startup Rivian.

Bad news on the trade war front appears to have led to a fall in the broader US equity markets today. Cannabis ETFs were also trading in the red.

Energy Transfer (ET) stock has recovered in the last two trading sessions after investors hammered it on its plans to acquire SemGroup (SEMG).

Software-as-a-service company Datadog (DDOG) made a smashing debut on Wall Street yesterday. After its IPO, DDOG's shares surged 40% in intraday trading.